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Abstract
Bacillus anthracis infectshostsasa spore, germinates,anddisseminatesinitsvegetative form.Production ofanthraxlethaland
edema toxins following bacterial outgrowth results in host death. Macrophages of inbred mouse strains are either sensitive or
resistant to lethal toxin depending on whether they express the lethal toxin responsive or non-responsive alleles of the
inflammasome sensor Nlrp1b (Nlrp1b
S/S or Nlrp1b
R/R, respectively). In this study, Nlrp1b was shown to affect mouse
susceptibility to infection. Inbred and congenic mice harboring macrophage-sensitizing Nlrp1b
S/S alleles (which allow
activation of caspase-1 and IL-1b release in response to anthrax lethal toxin challenge) effectively controlled bacterial growth
and dissemination when compared to mice having Nlrp1b
R/R alleles (which cannot activate caspase-1 in response to toxin).
Nlrp1b
S-mediated resistance to infection was not dependent on the route of infection and was observed when bacteria were
introduced by either subcutaneous or intravenous routes. Resistance did not occur through alterations in spore germination,
as vegetative bacteria were also killed in Nlrp1b
S/S mice. Resistance to infection required the actions of both caspase-1 and IL-
1b as Nlrp1b
S/S mice deleted of caspase-1 or the IL-1 receptor, or treated with the Il-1 receptor antagonist anakinra, were
sensitized to infection. Comparison of circulating neutrophil levels and IL-1b responses in Nlrp1b
S/S,
Nlrp1b
R/R and IL-1 receptor knockout mice implicated Nlrp1b and IL-1 signaling in control of neutrophil responses to anthrax
infection. Neutrophil depletion experiments verified the importance of this cell type in resistance to B. anthracis infection.
These data confirm an inverse relationship between murine macrophage sensitivity to lethal toxin and mouse susceptibility to
spore infection, and establish roles for Nlrp1b
S, caspase-1, and IL-1b in countering anthrax infection.
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Introduction
Anthrax disease occurs following germination of Bacillus anthracis
spores that enter an animal host through inhalational, oral, or
cutaneous routes. Anthrax lethal toxin (LT), responsible for the
lethality associated with terminal anthrax disease, is composed of
two polypeptides. LF (lethal factor, a protease) is transported into
the cytosol by PA (protective antigen, the cell-binding component).
LF cleaves members of the mitogen-activated protein kinase kinase
family (MEKs) [1–2]. LF’s proteolytic activity is required for its
ability to induce vascular collapse in animals and for the rapid lysis
of macrophages and dendritic cells from certain inbred rodent
strains (for review see [3]). The link between the cleavage of MEKs
and LT’s cytotoxic effects in macrophages and animals is currently
unknown.
The genetic locus controlling the susceptibility of mouse and rat
macrophages to LT has been mapped to Nlrp1b, a gene encoding a
member of the NLR (Nod-like receptor) protein family [4,5]. NLR
proteins are the sensor components of inflammasome complexes
which recruit and activate caspase-1 in response to intracellular
danger signals [6,7]. LT activates caspase-1 only in macrophages
from mice harboring Nlrp1b
S/S alleles, which express Nlrp1b
S
proteins containing the polymorphisms required for LT respon-
siveness. Macrophages from mice harboring Nlrp1b
R/R alleles and
expressing Nlrp1b
R proteins are resistant to LT. Caspase-1
activation in Nlrp1b
S expressing macrophages is required for rapid
LT-mediated lysis [4,8,9]. Earlier in vivo studies of LT-treated mice
showed that rapid, transcription-independent IL-1b release occurs
only in mouse strains having LT-sensitive macrophages (Nlrp1b
S/S)
[10,11]. While the LT-inducedactivation of caspase-1,macrophage
lysis, and IL-1b release in mice expressing Nlrp1b
S leads to a strong
cytokine burst, this macrophage response is not consistently
predictive of increased whole animal sensitivity to LT [10]. C3H/
HeJ and C3H/HeOuJ mice, for example, harbor Nlrp1b
S/S alleles
but are resistant to toxin doses that kill some inbred strains having
Nlrp1b
R/R alleles [10].
LT also plays a role in the early stages of anthrax infection, prior
to eliciting its systemic toxic effects. Bacterial dissemination and
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and anthrax toxin receptor knockout mice [13] provide evidence
of LT’s significant contribution to establishing infection. Some in
vitro analyses suggest that toxin action is required for release of
dividing intracellular bacteria from macrophages [14] or for spore
survival against killing by macrophages [15]. In turn, while some
reports suggest macrophages are required for the germination and
transportation of spores from the site of infection to regional
lymph nodes [14,16], other investigations have indicated that the
macrophage plays a protective role by killing spores [17–19].
We investigated the role of Nlrp1b in several anthrax infection
models to form a better understanding of LT’s role in establishing
disease. Our data confirm an inverse relationship between murine
macrophage sensitivity to LT and mouse susceptibility to spore
infection. We demonstrate that the activation of the inflamma-
some in response to anthrax infection in mice is a protective event.
Mice expressing Nlrp1b
S and harboring LT-sensitive macrophag-
es were resistant to infection by both spores and vegetative bacteria
at doses lethal to Nlrp1b
R-expressing mice harboring LT-resistant
macrophages. This Nlrp1b
S-mediated resistance to B. anthracis
infection required both caspase-1 and IL-1b mediated control of
neutrophil responses. We propose a role for LT-mediated, Nlrp1b-
dependent caspase-1 activation and IL-1b release in the control of
B. anthracis infection.
Results
Susceptibility of inbred mouse strains to spore infection
is controlled by Nlrp1b
An initial survey of subcutaneous infection of 11 inbred mouse
strains with the Ames 35 (A35) B. anthracis strain at four doses
(1610
8,2 610
7,2 610
6 and 2610
5 spores/mouse) identified a range
of sensitivities to infection (Fig. 1, and data not shown).
Approximately half of the commonly studied inbred mouse strains
are deficient in complement C5. We noted that all complement C5
component-deficient mice (C
2) were fully susceptible to the lowest
spore dose (2610
5). At doses below 1610
8, all complement-
sufficient (C
+) strains (Balb/cJ, Cast/EiJ, C3H/HeJ, C3H/HeOuJ)
except one (C57BL/6J) were resistant to infection (Fig. 1A, 1B, and
data not shown). The observation that complement sufficiency
contributed to resistance to spore infection supported previous
findings [20–22]. However, we found that within both the C
2 and
C
+ groups, mice harboring Nlrp1b
R/R alleles, and thus LT-resistant
macrophages, were significantly more susceptible to spore infection
than Nlrp1b
S/S mice harboring LT-sensitive macrophages (Fig. 1A,
1B). Spore infections in congenic mice harboring Nlrp1b
S/S or
Nlrp1b
R/R alleles on a C57BL/6NTac background confirmed that
Nlrp1b
S expression conferred a higher degree of resistance to spore
infection (Fig. 1C), supporting similar findings by other investigators
using Nlrp1b
S transgenic mice [23]. Thus, Nlrp1b
S appears to
manifest a protective effect independent of complement status.
Nlrp1b controls B. anthracis clearance and dissemination
Analysis of bacterial dissemination 24–32 h after subcutaneous
(SC) spore infection (2610
7/mouse) in 10 inbred strains showed
that C
2 strains expressing Nlrp1b
R (NOD/ShiLtJ, A/J, and DBA/
2J) had higher bacterial counts in organs (pooled spleen, liver and
kidney) than their C
2 Nlrp1b
S-expressing counterparts (SWR/J,
FVB/NJ) (Fig. 2, see statistical comparisons for groups in legend).
Similarly, C
+ strains expressing Nlrp1b
R (C57BL/6J) had signifi-
cantly higher counts than their C
+ Nlrp1b
S-expressing counterparts
(Balb/cJ and Cast/EiJ). Thus, the Nlrp1b
S allele appeared to inhibit
control of bacterial spread and growth compared to the Nlrp1b
R
allele, irrespective of complement status. Similar results were
obtained for dissemination to the lung (data not shown).
Nlrp1b does not alter germination efficiency
Nlrp1b
S- and Nlrp1b
R-expressing mice were compared for differ-
ences in their support of spore germination at the initial infection site
by measuring edema toxin production (and resultant local edema),
which can occur only after germination. Foreleg inoculation of
2610
7 spores in a small volume (50 ml) produced a local, restricted
edematous lesion that could be quantified by measuring its anterior
to posterior and sagittal dorsal/ventral dimensions. Edema was
observed in all strains as early as 1–2 h following infection (data not
shown), and the sizes of the lesions in Nlrp1b
S- and Nlrp1b
R-
expressingstrainswerenotsignificantlydifferentover4–24 h(Fig.3).
Histological analyses of skin sections verified an almost complete
germination of spores within hours of infection (Fig. 3, inset), in a
manner that did not appear to require uptake by macrophages or
dendritic cells, which were not yet present in these sites. Thus,
bacterial germination at the injection site and resulting edema toxin
production occur independent of Nlrp1b status.
Nlrp1b
S mediates resistance to vegetative bacilli in a
manner independent of the route of infection
Further arguing against differences in germination playing any
role in Nlrp1b-mediated control of infection was the finding that
Nlrp1b
S also mediated resistance to SC infection with newly-
germinated (i.e., vegetative) bacilli (Fig. 4A, 4B, 4C). To test
whether Nlrp1b
S controls infection at the level of bacterial
dissemination from the skin to other sites, we circumvented the
dissemination step by directly introducing dividing vegetative
bacteria into circulation. Strikingly, however, even the IV delivery
of vegetative bacteria resulted in resistance of Nlrp1b
S-expressing
complement-sufficient mice relative to their counterpart Nlrp1b
R-
expressing mouse strains (Fig. 4D, 4E). Thus, Nlrp1b-mediated
differences were not due to effects on bacterial spread from
subcutaneous sites. In complement-deficient strains, however,
Nlrp1b
S-mediated resistance (tested here in FVB/NJ mice) was
found only with SC infections (Fig. 4C, and data not shown).
Nlrp1b
S did not impart resistance to these complement-deficient
strains if the apparent Nlrp1b
S-dependent inhibition of dissemi-
nation was overcome by introduction of vegetative bacteria into
the bloodstream (Fig. 4F).
Author Summary
In this study, we show that anthrax lethal toxin activation
of Nlrp1b in toxin-sensitive mouse macrophages imparts
resistance to infection. Inbred and congenic mice harbor-
ing macrophage-sensitizing Nlrp1b alleles control bacterial
growth and dissemination independent of infection route
or effects on germination efficiency. Knockout mice
demonstrate that resistance imparted by Nlrp1b requires
caspase-1 activity and IL-1 signaling. Mice in which lethal
toxin activates the Nlrp1b inflammasome show an IL-1b
response and increased neutrophil recruitment leading to
increased resistance to infection. Neutrophil depletion
experiments verify the importance of this cell type in
resistance to B. anthracis infection. These data confirm an
inverse relationship between murine macrophage sensi-
tivity to lethal toxin and mouse susceptibility to spore
infection and demonstrate that the activation of the
inflammasome in response to anthrax infection in mice is a
protective event that occurs through IL-1b induction of
neutrophil recruitment.
Nlrp1b Inflammasome Controls Resistance to Anthrax
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S-mediated resistance to infection requires
caspase-1 and IL-1b
We previously observed that the earliest event associated with
LT-mediated activation of Nlrp1b
S in Nlrp1b
S/S mice is the
appearance of IL-1b in circulation, occurring within 1.5–2.5 h
after toxin injection [10,11]. As caspase-1 and IL-1b have
previously been associated with resistance to bacterial infections
[24–26] and are also linked to macrophage killing of B. anthracis
[27], we hypothesized that the LT-dependent IL-1b response in
Nlrp1b
S-expressing mice might explain their relative resistance. We
generated Nlrp1b
S/SCasp1
2/2 mice (in the Balb/cJ background,
backcrossed four generations, N4). These mice harbor LT-resistant
macrophages and do not produce an IL-1b burst in response to LT
injection (data not shown). The mice were highly susceptible to
spore infection when compared to their Nlrp1b
S/SCasp1
+/2 and
Nlrp1b
S/SCasp1
+/+ (Balb/c backcrossed, N4) littermates (Fig. 5A),
implicating caspase-1 in Nlrp1b
S-mediated resistance to anthrax
infection. IL-1 receptor knockout mice (Nlrp1b
S/SIL1R
2/2) were
also tested against their wild type littermates (Nlrp1b
S/SIL1R
+/+)a n d
found to be sensitive to spore infection (Fig. 5B). The macrophages
Figure 1. Susceptibility of inbred, C57BL/6NTacNlrp1b
S/S and C57BL/6NTacNlrp1b
R/R mouse strains to subcutaneous spore infection.
Mice were injected SC with 2610
6 (A) or 2610
5 (B) spores and monitored for malaise. R indicates Nlrp1b
R/R genotype and LT-resistant macrophages
(plotted in blue). S indicates Nlrp1b
S/S genotype and LT-sensitive macrophages (plotted in red). C
2 and C
+ indicate complement C5 status, with closed
symbols used for C
2 strains and open circles for C
+ strains. For the representative experiments shown, n=5 for all strains. Similar results were
obtained in three independent experiments utilizing all strains except CBA/J, C3H/HeJ and C3H/HeOuJ, which were not used in subsequent studies.
For panel A, logrank-based P-values comparing survival curves of any of the NOD/ShiLtJ, A/J, DBA/2J, and AKR/J mice (C
2, Nlrp1b
R/R) with the SWR/J
and FVB/NJ (C
2, Nlrp1b
S/S) mice are ,0.0035. P-values comparing the C57BL/6J mice (C
+, Nlrp1b
R/R) to any of C3H/HeJ, C3H/HeOuJ, Balb/cJ, Cast/EiJ,
and CBA/J mice (C
+, Nlrp1b
S/S) are ,0.015. All survival curves for C
+ mice are significantly different than all survival curves for C
2 mice (P-values
,0.003) except C57BL/6J mice compared to FVB/NJ or SWR/J (P-value =0.063 for both comparisons). For panel B, P-values comparing survival curves
of any of the NOD/ShiLtJ, A/J, and DBA/2J mice (C
2, Nlrp1b
R/R) with the SWR/J and FVB/NJ mice (C
2, Nlrp1b
S/S) are ,0.004. Comparison of survival of
C57BL/6J mice to all other mice except FVB/NJ yields P-values ,0.0025. P-value for C57BL/6J compared to FVB/NJ survival is 0.0034. (C) C57BL/
6NTacNlrp1b
S/S and C57BL/6NTacNlrp1b
R/R mice (n=5/strain) were injected with 1610
7 spores and monitored. P-value (Logrank Test) comparing
these survival curves is 0.0133. Similar results were obtained in three independent experiments, and in two studies using 2610
7 spores.
doi:10.1371/journal.ppat.1001222.g001
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S/SCasp1
2/2 mice, were
LT-sensitive and the mice produced an IL-1b burst in response to
bolus LT injection in a manner similar to other Nlrp1b
S-expressing
mice (data not shown). However, the absence of IL-1 receptor
prevented IL-1b signaling in these mice. The sensitivity of these
mice to infection confirms that macrophage sensitivity to LT as a
result of Nlrp1b status does not necessarily correlate with resistance
to infection. Rather, it is likely the IL-1b generated in Nlrp1b
S-
expressing mice in response to LT is important to resistance. In fact,
IL-1b responses measured at very early times after infection in
various mice supported this hypothesis. C57BL/6NTac Nlrp1b
S/S
mice produced significantly higher levels of IL-1b than their
C57BL/6NTac Nlrp1b
R/R counterparts very early in infection,
when toxin production is relatively low. Differences in IL-1b
responses could not be discerned in the Balb/cJ and C57BL/6J
mice at these early times, likely due to the many genetic differences
which could influence their cytokine response to infection. Not
surprisingly, there was little to no measurable response in
Nlrp1b
S/SCasp1
2/2 mice, while Nlrp1b
S/SIL1R
2/2 mice had signif-
icant IL-1b production (Fig. 5C). Finally, resistant Nlrp1b
S-
expressing mice treated daily with the human IL-1 receptor
antagonist anakinra (shown to be effective in rodents [28–30]),
were sensitized to infection (Fig. 5D), confirming a role for IL-1
signaling in resistance to infection.
Nlrp1b
S, caspase-1, and IL-1 act to control infection by
enhancing neutrophil responses
We previously showed that LT injection in Balb/cJ mice
induces an Nlrp1b
S-dependent IL-1b release, the subsequent
induction of numerous cytokines and chemokines [10,11],
including the potent neutrophil chemokine KC (mouse IL-8),
leading to a massive increase in circulating neutrophils [11]. A
similar response was absent in Nlrp1b
R-expressing mice [10,11].
To confirm the importance of neutrophils in clearance of B.
anthracis bacteria, Balb/cJ (Nlrp1b
S/S) mice were depleted of
neutrophils by two different methods. Pre-treatment with
cyclophosphamide or anti-Ly-6G monoclonal antibody 1A8 [31]
sensitized Balb/cJ mice to a spore dose to which they are normally
resistant (Fig. 6A, 6B). The protective role of neutrophils was also
observed in infection trials in C57BL/6J, A/J, and SWR/J mice
(all harboring Nlrp1b
R/R), as they were similarly sensitized
following neutrophil depletion (data not shown). Histological
analyses of spore-infected Balb/cJ, C57BL/6NTac Nlrp1b
S/S,
C57BL/6NTac Nlrp1b
R/R and C57BL/6J animals showed similar
destruction of neutrophils at the boundaries of bacteria-neutrophil
interaction in SC sections for both mouse strains (Fig. 6C and data
not shown). Analysis of circulating neutrophil levels, however,
showed significantly higher numbers of neutrophils in Nlrp1b
S-
expressing mice (Fig. 6D) as early as 4 h following SC spore
infection, in a manner paralleling the higher numbers of
circulating neutrophils in Balb/cJ mice when compared to
C57BL/6J mice after bolus LT challenge [11]. Furthermore,
significantly lower circulating neutrophil numbers were also
associated with spore-sensitive Nlrp1b
S/S IL1R
2/2 mice, likely
due to their inability to respond to IL-1b (Fig. 6D). Thus, it
appears that Nlrp1b
S expressing mice may have a stronger
neutrophilic response to infection following the germination of B.
anthracis and toxin production, accounting for the resistance
associated with Nlrp1b status. Interestingly, we found that
CXCR2 (KC, IL-8 receptor) knockout mice in either Nlrp1b
R/R
or Nlrp1b
S/S backgrounds did not show differences in susceptibility
to SC spore infection from wild type littermate controls (data not
Figure 2. Bacterial CFU counts in organs following spore infection. Mice were injected with 2610
7 spores (SC) and spleen, liver and kidneys
were harvested at 24–32 h, pooled, and the bacterial numbers (CFU/mouse) in the combined organs were assessed by dilution plating. C
+,C
2, R, and
S designations are as in Fig. 1. Results represent three independent experiments and n values are n=9 for all strains except A/J (n=12), SWR/J
(n=12), C57BL/6J (n=13), CAST/EiJ (n=5), C57BL/6NTac Nlrp1b
R/R (n=6) and C57BL/6NTac Nlrp1b
S/S (n=8). F-test (which compares the variance
between groups) yields values .0.05 comparing all groups except the following, which have significant variance (,0.05): NOD/ShiLtJ vs. SWR/J, FVB/
NJ, C57BL/6J, Balb/cJ and Cast/EiJ, C57BL/6NTac Nlrp1b
S/S, C57BL/6NTac Nlrp1b
R/R; A/J vs. SWR/J, FVB/NJ, Balb/cJ and Cast/EiJ, C57BL/6NTac Nlrp1b
S/S,
C57BL/6NTac Nlrp1b
R/R; DBA/2J vs. Balb/cJ and Cast/EiJ, C57BL/6NTac Nlrp1b
S/S, C57BL/6NTac Nlrp1b
R/R; SWR/J vs. every group; FVB/NJ vs. every
group except C57BL/6NTac Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R; C57BL/6J vs. every group except A/J and DBA/2J. Balb/cJ and Cast/EiJ compared to
every group except C57BL/6NTac Nlrp1b
S/S. The P-value comparing variance between C57BL/6NTac Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R is 0.0145.
doi:10.1371/journal.ppat.1001222.g002
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antibody did not sensitize Balb/cJ mice to spore infection (data not
shown). Thus, IL-1b mediated control of neutrophil recruitment
does not appear to occur via the strong KC response that is
induced by LT strictly in Nlrp1b
S/S strains.
Discussion
We previously used anthrax toxin receptor knockout mice to
demonstrate that anthrax toxin is essential for bacterial dissem-
ination in the complement-sufficient C57BL/6 (Nlrp1b
R/R) back-
ground [13]. These results complemented findings in an aerosol
murine model using complement-deficient A/J mice (Nlrp1b
R/R)
infected with spores of Sterne strain mutants which were deleted
for individual toxin components [12]. Thus, in both C57BL/6J
and A/J strains (both Nlrp1b
R-expressors and harboring LT-
resistant macrophages), bacterial subversion of the host innate
immune response depends on LT (produced by the bacterium)
and host cell PA receptors (to allow LF to enter cells). These earlier
findings fit well with the general consensus that LT impairment of
the innate immune response in a variety of cells aids in establishing
disease at early stages of B. anthracis infection (for review, see [32]).
The role of toxin in spore infection in Nlrp1b
S-expressing mice
harboring LT-sensitive macrophages appears to be quite different.
Data presented here indicate that in these animals the role of toxin
is likely defined by a balance between its inhibition of immune cell
function through targeting the MEK-pathways (which also occurs
in Nlrp1b
R-expressing mice) and the consequences of Nlrp1b
S
status in macrophages and/or other cell types. Our findings
indicate that the Nlrp1b
S allele confers relative resistance to spore
infection, supporting findings reported using Nlrp1b transgenic
mice [23]. Furthermore, we find that Nlrp1b-mediated resistance
requires both caspase-1 and IL-1b signaling.
We tested several hypotheses regarding mechanisms by which
Nlrp1b
S might impart resistance to infection. Nlrp1b status did not
affect spore germination, which occurred rapidly following SC
administration of spores and was observed in SC tissues that
appeared largely devoid of macrophages. This finding was
confirmatory of previous reports showing spore germination in
SC infection sites by 2 h after inoculation in both CBA/J (Nlrp1b
S/S)
and A/J (Nlrp1b
R/R) mice in a manner independent of complement
status [33]. Nlrp1b
S-mediated resistance to both SC and IV
infections with vegetative bacteria confirmed that Nlrp1b
S could
manifest its control of infections at steps subsequent to germination
of spores and dissemination of bacteria.
We hypothesize that Nlrp1b
S-mediated IL-1b release and its
associated cytokine and chemokine burst [10,11] may be the
initiating events providing a protective response against spore
infection in a complement-independent manner. IL-1b release
requires caspase-1 activity and its action requires functional IL-1
receptors. Nlrp1b
S/SCasp1
2/2 mice which harbored LT-resistant
macrophages and did not activate and release IL-1b in response to
LT injection were fully susceptible to infection when compared to
Nlrp1b
S/S Casp1
+/2 and Nlrp1b
S/S Casp1
+/+ littermates, confirming
that caspase-1 was required for Nlrp1b
S-mediated resistance to
anthrax infection. A similar result was obtained in a caspase-1
knockout mouse in the C3H/HeN (Nlrp1b
S/S) background, when
infection was by the intraperitoneal (IP) route [27]. IL-1 receptor
knockout mice harboring Nlrp1b
S/S alleles (Nlrp1b
S/SIL1R
2/2)w e r e
alsosusceptibletosporeinfection despite having LT-sensitive macro-
phages, activating caspase-1 and producing an IL-1b response to
LT. The sensitivity of these mice suggests that IL-1b signaling
activity is required for Nlrp1b
S-mediated resistance and that macro-
phage sensitivity to LT is not the determining factor in infection
outcome. Rather, the consequences of macrophage lysis (i.e., rapid
IL-1b release) may be the more important factor determining
resistance. Sensitization of resistant Nlrp1b
S-expressing mice follow-
ing treatment with an IL-1 receptor antagonist further confirms the
importance of IL-1b signaling in mediating Nlrp1b effects.
One mechanism through which Nlrp1b
S-dependent IL-1b
responses could control bacterial clearance is IL-1b mediated
neutrophil recruitment. Previous reports demonstrated a role for
neutrophils in control of Sterne infection in mice [33–36] and the
ability of human neutrophils to kill B. anthracis [37]. Data
supporting a potential role for neutrophils in controlling infection
in Nlrp1b
S-expressing mice came from prior studies showing the
induction of neutrophil chemokines accompanied by strikingly
high levels of circulating neutrophils in LT-treated Balb/cJ (but
not C57BL/6J) mice [11]. In the current study, we found
significantly higher levels of neutrophils in Nlrp1b
S-expressing
mice compared to Nlrp1b
R-expressing mice following infection.
These findings emphasize the role of Nlrp1b
S in differential
recruitment of neutrophils in response to anthrax infection. The
Figure 3. Nlrp1 does not control spore germination. Percent
increases in foot edema dorsal/ventral measurements relative to PBS-
treated controls are shown at 4, 8, and 24 h following spore injection
(2610
7,5 0ml, SC). P-values comparing Balb/cJ and C57BL/6J at all time
points were .0.388 (panel A). P-values comparing C57BL/6NTac
Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R at all three time points were
.0.5 (panel B). Inset panels show H&E (or B&H) staining of skin sections
in C57BL/6J (left) or Balb/cJ (right) mice 8 h after SC spore infection
(2610
7). Germinated bacteria can be seen in the upper half of each
panel with neutrophil influx in the lower half. Neutrophil influx was also
verified by myeloperoxidase immunostaining (not shown). Image is
taken at 4006magnification (scale bar =25 microns).
doi:10.1371/journal.ppat.1001222.g003
Nlrp1b Inflammasome Controls Resistance to Anthrax
PLoS Pathogens | www.plospathogens.org 5 December 2010 | Volume 6 | Issue 12 | e1001222observation that neutrophil depletion by either chemical or
biological methods leads to a significant sensitization of four
different mouse strains to anthrax infection further confirms the
role this cell type plays in resistance against B. anthracis infection.
The results in our current study point to the complexities
associated with the use of rodents as models for B. anthracis
infection. The wide range of susceptibilities associated with
complement status and the Nlrp1b-dependent control of infection
are described at length here. Human macrophages tested (to date)
are resistant to LT lysis (data not shown). Thus, complement-
sufficient Nlrp1
R mouse strains such as C57BL/6J may be the best
available mouse model for study of the response of human cells. It
would be interesting to search a range of animal species for the
presence of Nlrp1b
S alleles that confer protection against infection,
like the Nlrp1b
S alleles described here in mice. This could help to
determine whether evolutionary pressure has led to maintenance
of the Nlrp1b
S allele in these species.
Materials and Methods
Ethics Statement
All animal experiments were performed in strict accordance
with guidelines from the NIH and the Animal Welfare Act,
approved by the Animal Care and Use Committee of the National
Institute of Allergy and Infectious Diseases, National Institutes of
Health.
Bacteria
Spores were prepared from the nonencapsulated, toxigenic B.
anthracis Ames 35 (A35) strain [38] as previously described [39].
Briefly, bacteria were grown on sporulation agar at 37uC for 3
days followed by 4 days at 4uC, and were inspected by microscopy
to verify .95% sporulation. Spores were purified from plates by
four rounds of centrifugation and sterile water washes, followed by
heat treatment at 70uC for 30 min (to kill any vegetative bacteria).
For studies using vegetative bacteria, spores were grown in LB
broth and diluted in PBS prior to injection. Vegetative bacteria
were quantified by adsorption readings, with an A600 of 1.0
corresponding to a concentration of 2610
7 CFU/ml, as verified
by dilution plating. Spore quantification was performed using a
Petroff Hausser counting chamber (Hausser Scientific, Horsham,
PA) and verified by dilution plating.
Materials
Materials obtained from commercial sources included cyclo-
phosphamide (Baxter Healthcare, Deerfield, IL), neutralizing anti-
Figure 4. Susceptibility to infection with vegetative bacteria. Complement-sufficient Balb/cJ and C57BL/6J mice (panels A, D) or C57BL/6NTac
Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R mice (panels B, E) were challenged (1610
5 vegetative bacteria, 200 ml, SC (A, B) or IV (D, E)) and monitored for
survival. Complement-deficient NOD/ShiLtJ and FVB/NJ mice were challenged with 1610
4 vegetative bacteria SC (C) or IV (F) and monitored. Open
symbols denote mice harboring Nlrp1b
S and closed circles are used for mice harboring Nlrp1b
S. P-values for the comparison of the two curves in each
panel are ,0.01.
doi:10.1371/journal.ppat.1001222.g004
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antibody 1A8 (BD Pharmingen, San Diego, CA) and anakinra
(Kineret, Amgen, Thousand Oaks, CA).
Animals
All inbred mice were obtained from Jackson Laboratories (Bar
Harbor, Maine). IL-1 receptor knockout mice on a 129B6SF/2J
background (Jackson Laboratory B6;129S1-IL1r1
tm1Roml/J mice)
were genotyped and mice harboring Nlrp1b
S/S alleles were bred in
our facility to establish the Nlrp1b
S/SIL1R
2/2 line. C57BL/6NTac
Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R were generated from mice
that were previously described [10]. The parents for these mice
were generated through 7 backcrosses of previously described
C57Bl/6Ai-[KO]NOS2 mice homozygous for either the Nlrp1b
S or
Nlrp1b
R allele on the C57BL/6NTac background, and are
identical at .98% of loci. CXCR2
2/2 mice were generated at
the NIH by Drs. Ji-Liang Gao and Christophe Cataisson. We
created a complement-sufficient caspase-1 knockout mouse
homozygous for the Nlrp1b
S allele on the Balb/cJ background
through backcrossing NOD.129S2(B6)- Casp1
tm1Sesh/LtJ mice
(Jackson Laboratories)(Nlrp1b
R/R) with Balb/cJ mice (Nlrp1b
S/S),
followed by breeding of the F1 generation sibling mice (Casp1
+/2
X Nlrp1b
R/S). Nlrp1b
S/SCasp1
2/2 progeny were backcrossed to
Balb/cJ in this manner for four generations.
Genotyping
Nlrp1b genotype was determined by PCR (using the forward
primer: 59- AGG CAA GCA CAT TTG ACT TCA AGG T-39
and the reverse primer 59-GCT CAG TAG CTG CAT CTT
GCA TTT C-39) followed by XhoI digestion. Caspase-1
genotyping was by PCR. Wild type caspase-1 alleles were detected
by wild type-specific primer 59-GCA TGC CTG AAT AAT GAT
Figure 5. Nlrp1b
S-mediated resistance to infection requires caspase-1 and IL-1b. (A) Nlrp1b
S/SCasp1
2/2, Nlrp1b
S/SCasp1
+/2, and
Nlrp1b
S/SCasp1
+/+ mice (Balb/cJ background, N4), were infected with 2610
7 spores (SC) and monitored for survival. Numbers per group were as
follows: Nlrp1b
S/S Casp1
2/2 (n=10), Nlrp1b
S/S Casp1
+/2 (n=20), Nlrp1b
S/S Casp1
+/+ (n=6)). P-values for the comparison of the Nlrp1b
S/S Casp1
2/2 to
the three others strains are ,0.0001. (B) Sensitivity of IL-1 receptor knockout mice (Nlrp1b
S/SIL1R
2/2) was compared to Nlrp1b
S/SIL1R
+/+ (=B6129SF2/
J), Balb/cJ, and C57BL/6J mice (n=5/group) following challenge with 2610
7 spores (SC). Curve comparisons: Nlrp1b
S/SIL1R
2/2 vs. Nlrp1b
S/SIL1R
+/+
(P=0.0071); Nlrp1b
S/SIL1R
2/2 vs. Balb/cJ (P=0.0024). (C) Mice were infected with 5610
7 spores (SC) and IL-1b assessed in serum 6 h after infection.
Each data point represents an individual mouse. P-value comparing C57BL/6NTac Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R groups is 0.0062. P-value
comparing Balb/cJ and C57BL/6J groups is 0.68. P-values comparing the Nlrp1b
S/S Casp1
2/2 to any other group except C57BL/6NTac Nlrp1b
R/R are
,0.03. (D) Balb/cJ mice (n=5/group) were injected with 50 mg anakinra (IP) or PBS 1 h prior to spore infection, as well as 2, 6, 24, and 32 h post
infection. Infection was with 6610
7 spores (SC). P-value comparing the two curves is 0.0022.
doi:10.1371/journal.ppat.1001222.g005
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CAG AAG CC-39. The caspase-1 deleted allele was detected by
the amplification of a fragment in the presence of a caspase-1
deletion specific primer (59-GCG CCT CCC CTA CCC GG-39)
and the common primer.
Infection, dissemination, and edema studies
Mice were injected subcutaneously (SC, 200 ml) in the scruff of
the neck with various doses of spores prepared in PBS.
Alternatively, vegetative B. anthracis bacteria suspended in PBS
were injected SC (200 ml) or IV (200 ml). Infected animals were
monitored three times daily for 10 days for signs of malaise or
mortality. For IL-1b analyses, mice were bled and serum separator
tubes (Sarstedt, Newton, NC) were used to separate serum for
cytokine measurements. For cell blood count (CBC) analyses, mice
were bled by cardiac puncture directly into EDTA (5 mM)-coated
syringes and EDTA-coated blood collection tubes (Sarstedt,
Newton, NC). For neutrophil depletion by cyclophosphamide,
mice were treated with the drug IP (100 mg/kg, prepared in
500 ml PBS, 72 and 48 h prior to infection, and 200 mg/kg 24 h
prior to infection). For neutrophil depletion using antibody 1A8
(anti-Ly-6G), 100 mg of antibody prepared in PBS was injected
twice (IP), at 24 h and 6 h prior to spore infection of mice. For KC
neutralization, 100 mg of antibody prepared in PBS was injected
SC at the spore injection site 30 min prior to spore infection. For
anakinra studies, drug was diluted in PBS and injected IP (50 mg/
20 g mouse) 1 h prior to infection, as well as 2, 6, 24, and 32 h
post infection. In dissemination studies, organs (spleen, liver and
both kidneys) were collected from infected animals at 24 h after
infection and pooled prior to homogenization using a Tissue
Tearor Homogenizer (BioSpec Products, Oklahoma). Homoge-
nates were adjusted to the same volume (5 ml) in sterile PBS prior
to dilution and plating on LB agar for CFU assessment. Lung
preparations were made separately and processed similarly. In
experiments assessing leg edema following infection, 2610
7 spores
were injected SC in a specific location of each right foreleg in a
50 ml volume. This site was chosen to limit the ability of edema
spread, thus allowing consistent quantification of edema. Edema
was assessed at 1, 2, 4, 8, and 24 h after infection by measuring the
horizontal anterior/posterior and sagittal dorsal/ventral directions
using digital calipers (Mitutoyo Corporation, Aurora, IL).
Histological analyses
Skin and underlying edematous tissue sections were taken
following SC spore infection and fixed overnight in 10% formalin
followed by repeated 70% ethanol washes. Section preparation
and hematoxylin and eosin (H&E) staining were performed by
Histoserv, Inc. (Gaithersburg, MD).
IL-1b responses to lethal toxin and macrophage
sensitivity tests
Mice were injected with LF and PA purified as previously
described [40] and prepared in sterile PBS. The LF used here is a
recombinant protein having an N-terminal sequence beginning
HMAGG. Mice were injected IP with 100 mg of LT (100 mgP A
plus 100 mg LF). IL-1b analyses wereperformed on serum bleeds by
ELISA as previously described [11]. LT toxicity studies on bone
marrow macrophages were performed as previously described [8].
Figure 6. Neutrophils protect against B. anthracis infection. Balb/cJ mice were treated with cyclophosphamide (A) or a neutrophil-depleting
antibody (B) prior to SC challenge with the dose of 1610
7 spores (to which they are normally resistant) and compared to PBS-treated controls
receiving the same spore challenge. P-values for comparison of the two curves in each panel are ,0.003. (C) H&E stain of infected skin sections taken
8 h after infection of Balb/cJ and C57BL/6J mice. Left panels represent images taken at 506 (scale bar=200 micron); right panels are higher
magnification (4006) detail of a region from left panels showing the boundaries of bacteria and neutrophils (scale bar=25 microns). (D) C57BL/6NTac
Nlrp1b
S/S and C57BL/6NTac Nlrp1b
R/R and Nlrp1b
S/SIL1R
2/2 mice were infected with 6610
7 spores (SC) and cell blood counts analyzed after 4 h. The
neutrophil counts shown are for n=4 mice/group. Baseline neutrophil counts for uninfected mice were an average of 4.45610
8/ml. P-values
comparing any two groups are ,0.05.
doi:10.1371/journal.ppat.1001222.g006
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